Free Trial

Geode Capital Management LLC Raises Stock Holdings in Chemed Co. (NYSE:CHE)

Chemed logo with Medical background
Remove Ads

Geode Capital Management LLC lifted its holdings in shares of Chemed Co. (NYSE:CHE - Free Report) by 1.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 340,409 shares of the company's stock after acquiring an additional 4,966 shares during the quarter. Geode Capital Management LLC owned 2.26% of Chemed worth $180,654,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of CHE. UMB Bank n.a. grew its stake in Chemed by 300.0% in the 4th quarter. UMB Bank n.a. now owns 52 shares of the company's stock valued at $28,000 after purchasing an additional 39 shares during the period. Atala Financial Inc purchased a new position in shares of Chemed in the 4th quarter worth about $29,000. CBIZ Investment Advisory Services LLC grew its position in Chemed by 64.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after buying an additional 22 shares during the period. Trust Co. of Vermont purchased a new stake in Chemed during the fourth quarter worth about $34,000. Finally, Tortoise Investment Management LLC raised its position in Chemed by 77.3% in the fourth quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock worth $41,000 after acquiring an additional 34 shares during the period. 95.85% of the stock is currently owned by institutional investors.

Chemed Stock Up 0.2 %

CHE traded up $1.05 during trading hours on Friday, hitting $591.44. The stock had a trading volume of 104,450 shares, compared to its average volume of 97,198. The stock has a market cap of $8.64 billion, a PE ratio of 29.89, a price-to-earnings-growth ratio of 2.15 and a beta of 0.49. Chemed Co. has a 1 year low of $512.12 and a 1 year high of $625.09. The company's fifty day simple moving average is $583.16 and its 200 day simple moving average is $567.95.

Remove Ads

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.34%. The ex-dividend date was Monday, February 24th. Chemed's payout ratio is currently 10.05%.

Insider Activity at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 1,000 shares of the stock in a transaction on Monday, March 31st. The stock was sold at an average price of $615.33, for a total transaction of $615,330.00. Following the sale, the chief executive officer now owns 101,679 shares in the company, valued at $62,566,139.07. This represents a 0.97 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 3.32% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on CHE shares. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. Royal Bank of Canada increased their price objective on Chemed from $633.00 to $667.00 and gave the company an "outperform" rating in a report on Friday, March 14th.

View Our Latest Analysis on Chemed

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Featured Stories

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads